Lv4
800 积分 2023-08-09 加入
A review of chemotherapy in gastric cancer
2天前
已完结
Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial
2天前
已完结
Efficacy and safety of weekly paclitaxel with or without ramucirumab as second-line therapy for the treatment of advanced gastric or gastroesophageal junction adenocarcinoma (RAINBOW-Asia): a randomised, multicentre, double-blind, phase 3 trial
2天前
已完结
First-line cadonilimab plus chemotherapy in HER2-negative advanced gastric or gastroesophageal junction adenocarcinoma: a randomized, double-blind, phase 3 trial
4天前
已完结
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial
7天前
已完结
Diagnostic Value of Joint Detection of Serum TK1, TSGF, CA199, and CA724 for Gastric Cancer and Its Relationship With Clinicopathologic Features and Prognosis
8天前
已完结
Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer
9天前
已完结
The preclinical discovery and development of zolbetuximab for the treatment of gastric cancer
10天前
已完结
Immunotherapy and targeted therapy as first-line treatment for advanced gastric cancer
10天前
已完结
Regulatory T cells converted from Th1 cells in tumors suppress cancer immunity via CD39
11天前
已完结
皖公网安备34019202002308
